HCPCS G9208: Hepatitis C Genotype Testing Not Documented

HCPCS Level II code G9208 denotes that hepatitis C genotype testing was not documented as performed within 12 months before starting antiviral treatment, with no reason provided. The code is used to flag missing documentation that can affect clinical decision-making, treatment selection and quality reporting at a national level. Accurate documentation of genotype testing matters because genotype information can influence antiviral regimen choice and is often part of quality measurement for hepatitis C care.

This analysis covers national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise explanation of the code's purpose, the clinical context of genotype testing before antiviral initiation, and what elements are typically examined when this code is present. The publication outlines common benchmarks and reporting uses for codes that indicate missing tests, summarizes potential implications for coding and quality measurement, and highlights relevant policy considerations and clinical context affecting documentation practices.

The content is intended to inform coding professionals, compliance officers, and clinical administrators about the role of G9208 in claims and quality workflows, and to provide clarity on the code's meaning and typical application in outpatient antiviral treatment settings.

Billing Code Overview

HCPCS Level II code G9208 indicates that hepatitis C genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis C, reason not given. This code captures a documentation gap related to genotype testing for patients starting antiviral therapy.

Service type: Documentation of hepatitis C genotype testing status prior to antiviral treatment initiation
Typical site of service: Outpatient clinics or ambulatory care settings where antiviral treatment for hepatitis C is initiated. Data not available in the input.

Clinical Context

A 54-year-old patient with newly identified chronic hepatitis C infection presents to a hepatology clinic for initiation of direct-acting antiviral therapy. The clinician documents intent to start antiviral treatment but review of the chart and laboratory records shows no documented hepatitis C genotype testing within the prior 12 months. The clinic nurse contacts the patient for a blood draw to perform genotype (and viral load) testing; treatment initiation is deferred until genotype results are available or a documented reason for absence of testing is recorded. The typical workflow includes verification of prior labs in the electronic health record, ordering HCV RNA quantitative and HCV genotype testing if absent, counseling the patient on implications for regimen selection, documenting clinical justification if genotype testing cannot be obtained, and using billing code G9208 if genotype testing was not documented within 12 months and no reason is given.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the physician’s interpretation of a diagnostic laboratory result (rare for lab tests billed by reference labs).

Taxonomy Code	Specialty	Notes
`207RH0000X`	Gastroenterology	Specialists who commonly manage hepatitis C and order genotype testing.
`207RR0500X`	Transplant Hepatology	Manages complex hepatitis C cases, especially pre- and post-liver transplant.
`207L00000X`	Infectious Disease	Often consulted for antiviral regimen selection in HCV management.
`208000000X`	Family Medicine	Primary care clinicians who diagnose HCV and initiate testing and referrals.
`207K00000X`	Internal Medicine	Hospital- and clinic-based physicians who manage HCV testing and treatment initiation.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`86803`	Hepatitis C antibody, quantitative (e.g., ELISA)	Often performed initially to screen for HCV infection prior to genotype testing.
`87522`	Infectious agent detection by nucleic acid (e.g., HCV RNA), overtly quantitative, single step method	Provides viral load information essential for treatment decisions alongside genotype.
`87521`	Infectious agent detection by nucleic acid (e.g., HCV RNA), qualitative	Used for initial confirmation of active HCV infection prior to genotype testing.
`81479`	Unlisted molecular pathology procedure	Occasionally used when specific genotype subtyping methods not otherwise categorized are performed.
`G0472`	Hepatitis B surface antigen screening for HCPs (note: cross-check per payer)	Performed as part of comprehensive viral hepatitis evaluation when initiating HCV therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`B18.2`	Chronic viral hepatitis C	Primary diagnosis prompting genotype testing prior to antiviral therapy.
`Z79.899`	Other long term (current) drug therapy	May be used when documenting ongoing antiviral therapy; relevant to treatment planning.
`Z22.52`	Carrier of viral hepatitis C	Identifies patients known to carry HCV who may require genotype testing before therapy.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	Relevant when co-infections are assessed; influences HCV management complexity.
`K76.9`	Liver disease, unspecified	Used when liver disease is present and genotype guides treatment urgency and selection.

OpenPayer

Summary & Overview